Skip to content
health.tifoa.org
Discover the Hyperbaric Oxygen Therapy. A research project by TIFOA.
  • About
    • Disclaimer
  • Knowledge base
    • Basic Information
      • Technical Overview
      • History of Hyperbaric Medicine and HBOT
        • From Diving to Diagnosis
      • Definition of HBOT
      • Use and Acceptance of HBOT
      • Clinical Case Studies
      • Types of Hyperbaric Chambers, Unique Features and Applications
        • Monoplace Chambers
        • Multiplace Chambers
        • Mild Chambers
        • Alternate Designs
        • Architecture and Construction Requirements
    • Preparing for the Treatment
      • Vitamins
      • Nutritional Assessment
      • Considerations for all Diabetic Patients
      • Patient Education
      • Benefits of HBOT
      • Side Effects
        • Claustrophobia/Confinement Anxiety
    • Risks and Safety of HBOT
      • Oxygen Toxicity
      • Pulmonary Toxicity
      • Hyperoxic Myopia
      • Barotrauma
      • Contraindications
        • Relative Contraindications
      • Safety Policies and Procedures
      • Safety Precautions
      • Fire Potential in HBO Chambers
    • Treatment Indications
      • A
        • Intracranial Abscess
        • Exceptional Blood Loss Anemia
        • Acute Peripheral Arterial Insufficiency
      • B
        • Bone Damage
        • Thermal Burns
      • C
        • Cosmetic Surgery
      • D
        • Decompression Sickness (DCS)
        • Diabetic Wounds
      • E
        • Arterial Gas Embolism (AGE)/Intravascular Gas Embolism (IGE)
      • G
        • Gas Gangrene
      • H
        • HIV/AIDS
          • HBOT and HIV
          • Cost Effectiveness
          • Treating Specific Conditions with HBOT
            • Pulmonary Complications
            • Neurologic Manifestations of HIV
            • Dermatologic Manifestations
            • Ocular Disorders
            • Metabolic Disorders
            • Liver Problems
            • Psychological Issues
          • Hyperbaric Oxygen Therapy Clinic and Peer Support
          • Terminal Stages
          • HBOT and Concurrent Pharmacological Therapies
      • I
        • Infections
        • Progressive Necrotizing Infection (Meleney’s Ulcer)
      • O
        • Central Retinal Artery Occlusion (CRAO)
        • Refractory Osteomyelitis
      • P
        • Acute Cyanide Poisoning
        • Carbon Monoxide Poisoning and CO Poisoning Complicated by Cyanide Poisoning
      • R
        • Radiation Tissue Damage
      • S
        • Compromised Skin Grafts and Flaps
      • T
        • Tinnitus and Hearing Loss
    • Applications for HBOT
      • HBOT and Inflammation Response
        • Inflammatory Reaction
        • Systemic Inflammation
      • HBOT and Cellular Changes
      • HBOT Mechanisms of Action
    • “Off-Label” Uses for HBOT
      • Stroke
        • History of HBOT as a Stroke Therapy
      • Traumatic Brain Injury (TBI)
      • Autism
        • Autism and Gastrointestinal Inflammation
        • Neurotransmitter abnormalities
        • Dysbiosis
      • Multiple Sclerosis
    • Areas of Current Research
      • Pediatric research
      • Neurological research
      • Wound Care research
      • Surgical and Pharma-Therapeutics research
    • Authorities in HBOT
      • Leading Authorities in HBOT
        • Thomas M. Bozzuto, D.O.
        • Paul Harch, M.D.
        • K. K. Jain, M.D.
        • Eric P. Kindwall, M.D.
        • Richard A. Neubauer, M.D.
      • Other Notable Experts
    • Education
      • Physician Training for HBOT in the U.S.
      • Diving Organizations
    • Other aspects of HBOT
      • HBOT in Celebrity Popular Culture
      • HBOT in Science Fiction
      • HBOT in Mainstream News
      • HBOT in Sports Medicine
      • HBOT in Politics
    • Related
      • Medical Conditions and Disease Indications for HBOT Use
      • Regulatory Organizations
        • American Society of Mechanical Engineers (ASME)
        • National Fire Protection Association (NFPA)
        • Food and Drug Administration (FDA)
      • U. S. HBOT Centers
      • High Pressure Processing for the Food Industry
      • HBOT in the Cosmetic and Pharmaceutical Industries
  • New Home

P

  • Acute Cyanide Poisoning
  • Carbon Monoxide Poisoning and CO Poisoning Complicated by Cyanide Poisoning

Find Us

Address
123 Main Street
New York, NY 10001

Hours
Monday—Friday: 9:00AM–5:00PM
Saturday & Sunday: 11:00AM–3:00PM

About This Site

This may be a good place to introduce yourself and your site or include some credits.

Find Us

Address
123 Main Street
New York, NY 10001

Hours
Monday—Friday: 9:00AM–5:00PM
Saturday & Sunday: 11:00AM–3:00PM

© 2025 health.tifoa.org
Powered by WordPress | Theme: Graphy by Themegraphy